Aspen Labs Mexico – Carlos Abelleyra Cordero, CEO Spanish LATAM
Aspen Labs wants Latin America to be the third pillar of success for the company, and is doing it in a different way. The CEO for Spanish Latin America discusses…
Ranked as the ninth largest generic company in the world, South African-based Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories. The Group currently has 50 business units , 26 manufacturing facilities at 18 sites on 6 continents and approximately 8200 employees. In Latin America Aspen supplies a range of quality affordable products through its affiliate companies in Mexico, Argentina, Brazil and Venezuela as well as across the rest of Latin America in countries such as Chile, Colombia, Ecuador and the Carricam territories. Aspen sees Latin America as one of its key strategic regions with significant growth potential within the Group, and continues to seek opportunities to establish a greater presence in other Latin American countries.
Contact Details
Aspen Labs, S.A. De C.V.
Av. Insurgentes Sur 1685
Col. Guadalupe Inn, Del. Alvaro Obregón
C.P. 01020 México D.F.
Tel: +52 (55) 9126 0860
Website: aspenlabs.com.mx
Aspen Labs wants Latin America to be the third pillar of success for the company, and is doing it in a different way. The CEO for Spanish Latin America discusses…
The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and manufacturing infrastructure”. What was the original strategy behind getting…
The Mexican National Association of Drug Manufacturers (ANAFAM) aims to support its members through advocacy, regulatory support, and professional development. The association’s president, Dr Miguel Lombera, emphasises the importance of…
Dr Germán Fajardo currently serves as Director General of Health Services at leading Mexican university UNAM, having previously been director of its Faculty of Medicine. In conversation Dr Fajardo emphasises…
Gisela Ayala outlines the Mexican Diabetes Federation’s focus on educating people with diabetes, healthcare providers, and the general public to dispel myths and improve diabetes management. She highlights the significant…
Present in Mexico for over 50 years, the medical device firm Medtronic boasts a large manufacturing footprint in the country. VP for North and Latin America and president of the…
Joao Carapeto outlines Roche Diagnostics’ commitment to innovation, prevention, and diagnostics, emphasizing the need for robust partnerships and increased investment in early detection to address Mexico’s healthcare challenges. He highlights…
FUNSALUD is a leading Mexican think tank focused on improving public health through research, advocacy, and promoting public-private partnerships. As Mexico prepares to welcome a new president, FUNSALUD’s Hector Valle…
This year has seen no less than five GM changes at international pharma companies’ Mexican affiliates. Pfizer, MSD, Roche, Sanofi and Gilead have all taken on new local leadership. In…
Drawing on an industry track record of over 25 years, Fernando Fogarin has recently become the strategic project lead for emerging markets at women’s health specialist Organon. He shares his…
Mexico’s president-elect Claudia Sheinbaum recently revealed some of her key cabinet choices, naming eminent physician and researcher David Kershenobich as the country’s new health secretary. When Kershenobich takes office in…
The Mexican Diabetes Association (AMD) is an organization dedicated to providing education and training to Mexicans living with diabetes and their families. President Gabriela Allard comments on the importance of…
As the country’s most important patient organization for cancer, the Mexican Association for the Fight Against Cancer (AMLCC) focuses on education, prevention and patient support, as well as on influencing…
Federico Prince, general manager and CEO of Laboratorios Kener details the family-run branded generics company’s changing of hands and the rocky patches it went through before becoming the second-largest company…
See our Cookie Privacy Policy Here
